ENP Newswire - 09 October 2012
Release date- 08102012 - Utrecht, The Netherlands - The University Medical Center Utrecht (Utrecht, The Netherlands) and Royal Philips Electronics (NYSE:PHG, AEX:PHIA) today announced that they have started a pilot clinical study to evaluate a new treatment for breast cancer based on a technology called MR-guided High Intensity Focused Ultrasound (MR-HIFU).
To facilitate this study, Philips has built a dedicated investigational system optimized for the anatomy of the female breast. The first patient in the study has already been treated using the system.
Thanks to Equities.com